[
    [
        {
            "time": "",
            "original_text": "华金证券维持益丰药店增持评级：业绩持续高增，内生稳健外延加速",
            "features": {
                "keywords": [
                    "益丰药店",
                    "增持评级",
                    "业绩高增",
                    "内生稳健",
                    "外延加速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华金证券维持益丰药店增持评级：业绩持续高增，内生稳健外延加速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "平安证券维持益丰药店推荐评级：公司加速扩张，一季报业绩维持高速增长",
            "features": {
                "keywords": [
                    "益丰药店",
                    "推荐评级",
                    "加速扩张",
                    "一季报",
                    "业绩高增"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券维持益丰药店推荐评级：公司加速扩张，一季报业绩维持高速增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "39家公司获得推荐评级 - 更新中",
            "features": {
                "keywords": [
                    "推荐评级",
                    "更新中"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "39家公司获得推荐评级 - 更新中",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "【国元医药|点评】一心堂2021年一季报点评：业绩维持稳健增长，门店布局加速扩张",
            "features": {
                "keywords": [
                    "国元医药",
                    "一心堂",
                    "一季报",
                    "业绩稳健增长",
                    "门店扩张"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国元医药|点评】一心堂2021年一季报点评：业绩维持稳健增长，门店布局加速扩张",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "国金证券维持益丰药店买入评级：稳健扩张，全年业绩有望维持高速增长",
            "features": {
                "keywords": [
                    "国金证券",
                    "益丰药店",
                    "买入评级",
                    "稳健扩张",
                    "全年业绩高增"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国金证券维持益丰药店买入评级：稳健扩张，全年业绩有望维持高速增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【国元医药|点评】老百姓2020年年报&2021年一季报点评：门店布局扩张加速，业绩增速短期承压",
            "features": {
                "keywords": [
                    "国元医药",
                    "老百姓",
                    "年报",
                    "一季报",
                    "门店扩张",
                    "业绩承压"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【国元医药|点评】老百姓2020年年报&2021年一季报点评：门店布局扩张加速，业绩增速短期承压",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "【益丰药房|一季报点评】门店稳健扩张，2021Q1业绩高增长符合预期【安信医药马帅团队】",
            "features": {
                "keywords": [
                    "益丰药房",
                    "一季报",
                    "门店扩张",
                    "业绩高增长",
                    "符合预期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【益丰药房|一季报点评】门店稳健扩张，2021Q1业绩高增长符合预期【安信医药马帅团队】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "益丰药房：2021年第一季度净利润约2.41亿元，同比增加29.39%",
            "features": {
                "keywords": [
                    "益丰药房",
                    "第一季度",
                    "净利润",
                    "同比增加"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益丰药房：2021年第一季度净利润约2.41亿元，同比增加29.39%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]